Oncofertility for neurosurgery
In recent years, more cancer patients are achieving long-term survival owing to advances after cancer treatment. The effects of treatment on fertility are a great concern to many young people. For some, the loss of a future child may be more distressing than a cancer diagnosis itself, and indeed, a...
Saved in:
| Published in | Nervous System in Children Vol. 46; no. 4; pp. 273 - 278 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
The Japanese Society for Pediatric Neurosurgery
2021
一般社団法人 日本小児神経外科学会 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0387-8023 2435-824X |
| DOI | 10.34544/jspn.46.4_273 |
Cover
| Abstract | In recent years, more cancer patients are achieving long-term survival owing to advances after cancer treatment. The effects of treatment on fertility are a great concern to many young people. For some, the loss of a future child may be more distressing than a cancer diagnosis itself, and indeed, a cancer diagnosis does not change the desire for biological children. Consultation with fertility specialists before the initiation of cancer treatment offers the potential to optimize the potential of becoming biological parents in the future and minimize the effects of fertility impairment on quality of life (QOL).In 2006, Woodruff’s group established the Oncofertility Consortium, which is a nationwide network for coordination of oncologic and reproductive healthcare, and they also published clinical pocket guides to oncofertility for doctors and patients.In Japan, there has been no comprehensive guideline on fertility preservation in patients with specific cancers. Clinical oncologists in Japan should recognize the importance of fertility preservation in children, adolescents, and young adults (AYA) with cancer to improve survivorship. In 2015, the Japan Society of Clinical Oncology (JSCO) started to develop guidelines that focused on cancer treatment while taking fertility preservation into consideration. In 2017, JSCO completed the “2017 Clinical Practice Guidelines for Fertility Preservation in Pediatric, AYA Cancer Patients”.However, fertility preservation sometimes has to be abandoned depending on the stage of the cancer and the general condition of the patient, because fertility preservation procedures may unacceptably delay cancer treatment or be too risky for the patient. The clinician’s objective in most cases is to make a professional judgment regarding urgency of treatment and assess the likelihood of successful preservation in an ill individual. It is conceivable that clinicians considered discussions regarding future fertility were not considered appropriate.The importance of the role of the clinician in discussions and decisions regarding fertility preservation cannot be underestimated.Patients and their parents want information regarding risks, referral to fertility specialists has been contributing to lower regret and greater QOL for patients after cancer treatment and those who undergo fertility preservation believe they had made the right decision.In addition, important aspect of fertility counseling should include the reassessment of fertility after treatment has completed. For male, this can include reassessment of sperm count and motility, and for women, pre- and post-treatment blood test of anti-Mullerian hormone (AMH) can provide an indication of ovarian function.This article reviews the latest information concerning clinical practice guidelines around the world, including the American Society of Clinical Oncology guidelines that were to be published in neurosurgical field. |
|---|---|
| AbstractList | In recent years, more cancer patients are achieving long-term survival owing to advances after cancer treatment. The effects of treatment on fertility are a great concern to many young people. For some, the loss of a future child may be more distressing than a cancer diagnosis itself, and indeed, a cancer diagnosis does not change the desire for biological children. Consultation with fertility specialists before the initiation of cancer treatment offers the potential to optimize the potential of becoming biological parents in the future and minimize the effects of fertility impairment on quality of life (QOL).In 2006, Woodruff’s group established the Oncofertility Consortium, which is a nationwide network for coordination of oncologic and reproductive healthcare, and they also published clinical pocket guides to oncofertility for doctors and patients.In Japan, there has been no comprehensive guideline on fertility preservation in patients with specific cancers. Clinical oncologists in Japan should recognize the importance of fertility preservation in children, adolescents, and young adults (AYA) with cancer to improve survivorship. In 2015, the Japan Society of Clinical Oncology (JSCO) started to develop guidelines that focused on cancer treatment while taking fertility preservation into consideration. In 2017, JSCO completed the “2017 Clinical Practice Guidelines for Fertility Preservation in Pediatric, AYA Cancer Patients”.However, fertility preservation sometimes has to be abandoned depending on the stage of the cancer and the general condition of the patient, because fertility preservation procedures may unacceptably delay cancer treatment or be too risky for the patient. The clinician’s objective in most cases is to make a professional judgment regarding urgency of treatment and assess the likelihood of successful preservation in an ill individual. It is conceivable that clinicians considered discussions regarding future fertility were not considered appropriate.The importance of the role of the clinician in discussions and decisions regarding fertility preservation cannot be underestimated.Patients and their parents want information regarding risks, referral to fertility specialists has been contributing to lower regret and greater QOL for patients after cancer treatment and those who undergo fertility preservation believe they had made the right decision.In addition, important aspect of fertility counseling should include the reassessment of fertility after treatment has completed. For male, this can include reassessment of sperm count and motility, and for women, pre- and post-treatment blood test of anti-Mullerian hormone (AMH) can provide an indication of ovarian function.This article reviews the latest information concerning clinical practice guidelines around the world, including the American Society of Clinical Oncology guidelines that were to be published in neurosurgical field.
Oncofertilityとは，oncologyとfertilityをあわせた概念である．AYA世代に対する一部の外科・化学・放射線療法の結果生じる妊孕性低下はQOLを大きく損なう．限られた時間の中で適切な情報提供を行うには，主治医と生殖医療を専門とする医師との間の速やかで密な連携が重要である．近年，脳神経外科領域に対するoncofertilityの関心が高まっている．本稿では，ASCOのガイドライン（2006/2013）を中心に，脳神経外科とoncofertilityについて文献的考察を行う． In recent years, more cancer patients are achieving long-term survival owing to advances after cancer treatment. The effects of treatment on fertility are a great concern to many young people. For some, the loss of a future child may be more distressing than a cancer diagnosis itself, and indeed, a cancer diagnosis does not change the desire for biological children. Consultation with fertility specialists before the initiation of cancer treatment offers the potential to optimize the potential of becoming biological parents in the future and minimize the effects of fertility impairment on quality of life (QOL).In 2006, Woodruff’s group established the Oncofertility Consortium, which is a nationwide network for coordination of oncologic and reproductive healthcare, and they also published clinical pocket guides to oncofertility for doctors and patients.In Japan, there has been no comprehensive guideline on fertility preservation in patients with specific cancers. Clinical oncologists in Japan should recognize the importance of fertility preservation in children, adolescents, and young adults (AYA) with cancer to improve survivorship. In 2015, the Japan Society of Clinical Oncology (JSCO) started to develop guidelines that focused on cancer treatment while taking fertility preservation into consideration. In 2017, JSCO completed the “2017 Clinical Practice Guidelines for Fertility Preservation in Pediatric, AYA Cancer Patients”.However, fertility preservation sometimes has to be abandoned depending on the stage of the cancer and the general condition of the patient, because fertility preservation procedures may unacceptably delay cancer treatment or be too risky for the patient. The clinician’s objective in most cases is to make a professional judgment regarding urgency of treatment and assess the likelihood of successful preservation in an ill individual. It is conceivable that clinicians considered discussions regarding future fertility were not considered appropriate.The importance of the role of the clinician in discussions and decisions regarding fertility preservation cannot be underestimated.Patients and their parents want information regarding risks, referral to fertility specialists has been contributing to lower regret and greater QOL for patients after cancer treatment and those who undergo fertility preservation believe they had made the right decision.In addition, important aspect of fertility counseling should include the reassessment of fertility after treatment has completed. For male, this can include reassessment of sperm count and motility, and for women, pre- and post-treatment blood test of anti-Mullerian hormone (AMH) can provide an indication of ovarian function.This article reviews the latest information concerning clinical practice guidelines around the world, including the American Society of Clinical Oncology guidelines that were to be published in neurosurgical field. |
| Author | Sasano, Mari Yagasaki, Hiroshi Igarashi, Takahiro Kanezawa, Koji Hirai, Maiko Yoshino, Atsuo Oshima, Hideki Sumi, Koichiro |
| Author_FL | Igarashi Takahiro 谷ヶ﨑 博 大島 秀規 吉野 篤緒 Kanezawa Koji Sumi Koichiro 笹野 まり 平井 麻衣子 |
| Author_FL_xml | – sequence: 1 fullname: Igarashi Takahiro – sequence: 2 fullname: Kanezawa Koji – sequence: 3 fullname: 平井 麻衣子 – sequence: 4 fullname: Sumi Koichiro – sequence: 5 fullname: 笹野 まり – sequence: 6 fullname: 谷ヶ﨑 博 – sequence: 7 fullname: 大島 秀規 – sequence: 8 fullname: 吉野 篤緒 |
| Author_xml | – sequence: 1 fullname: Kanezawa, Koji organization: Department of Pediatrics, Center Hospital of the National Center for Global Health and Medicine – sequence: 1 fullname: Sumi, Koichiro organization: Department of Neurological Surgery, Nihon University School of Medicine – sequence: 1 fullname: Yoshino, Atsuo organization: Department of Neurological Surgery, Nihon University School of Medicine – sequence: 1 fullname: Yagasaki, Hiroshi organization: Department of Pediatrics, Nihon University School of Medicine – sequence: 1 fullname: Hirai, Maiko organization: Department of Pediatrics, Nihon University School of Medicine – sequence: 1 fullname: Sasano, Mari organization: Department of Neurological Surgery, Nihon University School of Medicine – sequence: 1 fullname: Oshima, Hideki organization: Department of Neurological Surgery, Nihon University School of Medicine – sequence: 1 fullname: Igarashi, Takahiro organization: Department of Neurological Surgery, Nihon University School of Medicine |
| BackLink | https://cir.nii.ac.jp/crid/1390009018101099648$$DView record in CiNii |
| BookMark | eNo9kM1rAjEUxEOxUGu99lg89Lr2Je_FvFwKRfoFghcPvYWQZO0uNitZPfjfd8XSy8xhfgzD3IpR7nIS4l7CHEkTPbX9Ps9pMSenDF6JsSLUFSv6GokxIJuKQeGNmPZ9CwCIkohpLB7WOXR1Kodm1xxOs7ors5yOpeuPZZvK6U5c137Xp-mfT8Tm7XWz_KhW6_fP5cuqapm4CnVUPlqq0URFIRBYxSZp0GSMjJ6N1ckGb6WKhoECo44W2CsZtVWIE_F4qc1N40JzVol22GlBsgQJ1i6IB-z5grX9wW-T25fmx5eT88P8sEvu_IGjhaOzDDf8B-HbF5cy_gLL1FYq |
| ContentType | Journal Article |
| Copyright | 2021 The Japanese Society for Pediatric Neurosurgery |
| Copyright_xml | – notice: 2021 The Japanese Society for Pediatric Neurosurgery |
| DBID | RYH |
| DOI | 10.34544/jspn.46.4_273 |
| DatabaseName | CiNii Complete |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | 脳神経外科とOncofertility：AYA世代脳腫瘍患者のがん・生殖医療について |
| DocumentTitle_FL | 脳神経外科とOncofertility：AYA世代脳腫瘍患者のがん・生殖医療について |
| EISSN | 2435-824X |
| EndPage | 278 |
| ExternalDocumentID | 130008132499 article_jspn_46_4_46_273_article_char_en |
| GroupedDBID | ABDBF ABJNI ALMA_UNASSIGNED_HOLDINGS JSF MOJWN RJT RYH |
| ID | FETCH-LOGICAL-j848-cfd2ad94f37d24cc409287e5054771da8795e9ca912d7804c835d908a21d59233 |
| ISSN | 0387-8023 |
| IngestDate | Thu Jun 26 22:15:32 EDT 2025 Wed Sep 03 06:30:58 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 4 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j848-cfd2ad94f37d24cc409287e5054771da8795e9ca912d7804c835d908a21d59233 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jspn/46/4/46_273/_article/-char/en |
| PageCount | 6 |
| ParticipantIDs | nii_cinii_1390009018101099648 jstage_primary_article_jspn_46_4_46_273_article_char_en |
| PublicationCentury | 2000 |
| PublicationDate | 2021 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – year: 2021 text: 2021 |
| PublicationDecade | 2020 |
| PublicationTitle | Nervous System in Children |
| PublicationTitleAlternate | Nervous System in Children |
| PublicationTitle_FL | 小児の脳神経 Nervous System in Children |
| PublicationYear | 2021 |
| Publisher | The Japanese Society for Pediatric Neurosurgery 一般社団法人 日本小児神経外科学会 |
| Publisher_xml | – name: The Japanese Society for Pediatric Neurosurgery – name: 一般社団法人 日本小児神経外科学会 |
| References | [4] Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A: Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364: 1405-1410, 2004. [15] Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K: American society of clinical oncology: fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 31: 2500-2510, 2013. [2] Coccia PF, Pappo AS, Altman J, Bhatia S, Borinstein SC, Flynn J, Frazier AL, George S, Goldsby R, Hayashi R, et al: Adolescent and young adult oncology, version 2. 2014. J Natl Compr Canc Netw 12: 21-32, 2014. [26] Wallace WH, Thomson AB, Saran F, Kelsey TW: Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 62: 738-744, 2005. [11] Kenney LB, Laufer MR, Grant FD, Grier H, Diller L: High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 91: 613-621, 2001. [17] Nangia AK, Krieg SA, Kim SS: Clinical guidelines for sperm cryopreservation in cancer patients. Fertil Steril 100: 1203-1209, 2013. [3] Dillon KE, Gracia CR: Pediatric and young adult patients and oncofertility. Curr Treat Options Oncol 13: 161-173, 2012. [19] Osterberg EC, Ramasamy R, Masson P, Brannigan RE: Current practices in fertility preservation in male cancer patients. Urol Ann 6: 13-17, 2014. [28] Woodruff TK: The oncofertility consortium addressing fertility in young people with cancer. Nat Rev Clin Oncol 7: 466-475, 2010. [16] Meirow D, Biederman H, Anderson RA, Wallace WH: Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 53: 727-739, 2010. [22] Rosendahl M, Schmidt KT, Ernst E, Rasmussen PE, Loft A, Byskov AG, Andersen AN, Andersen CY: Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod Biomed Online 22: 162-171, 2011. [7] Green DM, Nolan VG, Kawashima T, Stovall M, Donaldson SS, Srivastava D, Leisenring W, Robison LL, Sklar CA: Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study. Fertil Steril 95: 1922-1972. [8] Health and Disability Commissioner. Paediatric Oncologist, Dr B. Auckland District Health Board vs Mr. A. Case13HDC00475, Auckland, 2014. [10] Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, Wolf I, Kanety H, Sredni B, Meirow D: Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med 5: 185, 2013. [21] Roberts J, Ronn R, Tallon N, Holzer H: Fertility preservation in reproductive-age women facing gonadotoxic treatments. Curr Oncol 22: 294-304, 2015. [5] 古井辰郎，牧野弘，竹中基記，寺澤恵子，山本晃央，森重健一郎 : 特集 がん・生殖医療の連携体制構築へ向けて．産婦人科の実際 64: 1033-1037, 2015. [27] Williams D, Crofton PM, Levitt G: Does ifosfamide affect gonadal function? Pediatr Blood Cancer 50: 347-351, 2008. [20] Poirot C, Abirached F, Prades M, Coussieu C, Bernaudin F, Piver P: Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 379: 588, 2012. [13] 公益財団法人がん研究振興財団 : がんの統計16: 36-37, 2016. [18] Noyes N, Labella PA, Grifo J, Knopman JM: Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. J Assist Reprod Genet 27: 495-499, 2010. [23] Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, Barker N, Shroyer NF, van de Wetering M, Clevers H: Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469: 415-418, 2011. [14] Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K: American society of clinical oncology: American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24: 2917-2931, 2006. [25] van Dorp W, van den Heuvel-Eibrink MM, Stolk L, Pieters R, Uitterlinden AG, Visser JA, Laven JS: Genetic variation may modify ovarian reserve in female childhood cancer survivors. Hum Reprod 28: 1069-1076, 2013. [12] Keros V, Hultenby K, Borgström B, Fridström M, Jahnukainen K, Hovatta O: Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod 22: 1384-1395, 2007. [6] Furui T, Takenaka M, Makino H, Terazawa K, Yamamoto A, Morishige KI: An evaluation of the Gifu model in a trial for a new regional oncofertility network in Japan, focusing on its necessity and effects. Reprod Med Biol 15: 107-113, 2016. [24] 鈴木直 : 海外でのがん・生殖医療の取り組みと日本がん・生殖医療研究会の役割．鈴木直，竹原祐志編 : がん・生殖医療—妊孕性温存の診療．東京，医歯薬出版，2013, pp 250-259. [1] Bradford NK, Walker R, Henney R, Inglis P, Chan RJ: Improvements in clinical practice for fertility preservation among young cancer patients: Results from bundled interventions. J Adolesc Young Adult Oncol 7: 37-45, 2018. [9] Kadashev BA, Konovalov AN, Astaf’eva LI, Kalinin PL, Kutin MA, Klochkova IS, Fomichev DV, Sharipov OI, Andreev DN: Preoperative and postoperative endocrine disorders associated with pituitary stalk injuries caused by suprasellar growing tumors. Zh Vopr Neirokhir Im N N Burdenko 82: 13-21, 2018. |
| References_xml | – reference: [1] Bradford NK, Walker R, Henney R, Inglis P, Chan RJ: Improvements in clinical practice for fertility preservation among young cancer patients: Results from bundled interventions. J Adolesc Young Adult Oncol 7: 37-45, 2018. – reference: [11] Kenney LB, Laufer MR, Grant FD, Grier H, Diller L: High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 91: 613-621, 2001. – reference: [6] Furui T, Takenaka M, Makino H, Terazawa K, Yamamoto A, Morishige KI: An evaluation of the Gifu model in a trial for a new regional oncofertility network in Japan, focusing on its necessity and effects. Reprod Med Biol 15: 107-113, 2016. – reference: [10] Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, Wolf I, Kanety H, Sredni B, Meirow D: Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med 5: 185, 2013. – reference: [12] Keros V, Hultenby K, Borgström B, Fridström M, Jahnukainen K, Hovatta O: Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod 22: 1384-1395, 2007. – reference: [9] Kadashev BA, Konovalov AN, Astaf’eva LI, Kalinin PL, Kutin MA, Klochkova IS, Fomichev DV, Sharipov OI, Andreev DN: Preoperative and postoperative endocrine disorders associated with pituitary stalk injuries caused by suprasellar growing tumors. Zh Vopr Neirokhir Im N N Burdenko 82: 13-21, 2018. – reference: [21] Roberts J, Ronn R, Tallon N, Holzer H: Fertility preservation in reproductive-age women facing gonadotoxic treatments. Curr Oncol 22: 294-304, 2015. – reference: [22] Rosendahl M, Schmidt KT, Ernst E, Rasmussen PE, Loft A, Byskov AG, Andersen AN, Andersen CY: Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod Biomed Online 22: 162-171, 2011. – reference: [27] Williams D, Crofton PM, Levitt G: Does ifosfamide affect gonadal function? Pediatr Blood Cancer 50: 347-351, 2008. – reference: [7] Green DM, Nolan VG, Kawashima T, Stovall M, Donaldson SS, Srivastava D, Leisenring W, Robison LL, Sklar CA: Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study. Fertil Steril 95: 1922-1972. – reference: [15] Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K: American society of clinical oncology: fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 31: 2500-2510, 2013. – reference: [8] Health and Disability Commissioner. Paediatric Oncologist, Dr B. Auckland District Health Board vs Mr. A. Case13HDC00475, Auckland, 2014. – reference: [26] Wallace WH, Thomson AB, Saran F, Kelsey TW: Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 62: 738-744, 2005. – reference: [24] 鈴木直 : 海外でのがん・生殖医療の取り組みと日本がん・生殖医療研究会の役割．鈴木直，竹原祐志編 : がん・生殖医療—妊孕性温存の診療．東京，医歯薬出版，2013, pp 250-259. – reference: [3] Dillon KE, Gracia CR: Pediatric and young adult patients and oncofertility. Curr Treat Options Oncol 13: 161-173, 2012. – reference: [23] Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, Barker N, Shroyer NF, van de Wetering M, Clevers H: Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469: 415-418, 2011. – reference: [14] Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K: American society of clinical oncology: American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24: 2917-2931, 2006. – reference: [5] 古井辰郎，牧野弘，竹中基記，寺澤恵子，山本晃央，森重健一郎 : 特集 がん・生殖医療の連携体制構築へ向けて．産婦人科の実際 64: 1033-1037, 2015. – reference: [19] Osterberg EC, Ramasamy R, Masson P, Brannigan RE: Current practices in fertility preservation in male cancer patients. Urol Ann 6: 13-17, 2014. – reference: [13] 公益財団法人がん研究振興財団 : がんの統計16: 36-37, 2016. – reference: [20] Poirot C, Abirached F, Prades M, Coussieu C, Bernaudin F, Piver P: Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 379: 588, 2012. – reference: [16] Meirow D, Biederman H, Anderson RA, Wallace WH: Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 53: 727-739, 2010. – reference: [4] Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A: Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364: 1405-1410, 2004. – reference: [25] van Dorp W, van den Heuvel-Eibrink MM, Stolk L, Pieters R, Uitterlinden AG, Visser JA, Laven JS: Genetic variation may modify ovarian reserve in female childhood cancer survivors. Hum Reprod 28: 1069-1076, 2013. – reference: [28] Woodruff TK: The oncofertility consortium addressing fertility in young people with cancer. Nat Rev Clin Oncol 7: 466-475, 2010. – reference: [17] Nangia AK, Krieg SA, Kim SS: Clinical guidelines for sperm cryopreservation in cancer patients. Fertil Steril 100: 1203-1209, 2013. – reference: [18] Noyes N, Labella PA, Grifo J, Knopman JM: Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. J Assist Reprod Genet 27: 495-499, 2010. – reference: [2] Coccia PF, Pappo AS, Altman J, Bhatia S, Borinstein SC, Flynn J, Frazier AL, George S, Goldsby R, Hayashi R, et al: Adolescent and young adult oncology, version 2. 2014. J Natl Compr Canc Netw 12: 21-32, 2014. |
| SSID | ssj0003314484 ssib044760907 ssib000871981 ssib058494427 |
| Score | 2.2508118 |
| Snippet | In recent years, more cancer patients are achieving long-term survival owing to advances after cancer treatment. The effects of treatment on fertility are a... |
| SourceID | nii jstage |
| SourceType | Publisher |
| StartPage | 273 |
| SubjectTerms | adolescence and young adult (AYA) anti-Mullerian hormone (AMH) Infertility neurosurgery oncofertility |
| Title | Oncofertility for neurosurgery |
| URI | https://www.jstage.jst.go.jp/article/jspn/46/4/46_273/_article/-char/en https://cir.nii.ac.jp/crid/1390009018101099648 |
| Volume | 46 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Nervous System in Children, 2021, Vol.46(4), pp.273-278 |
| journalDatabaseRights | – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2435-824X dateEnd: 99991231 omitProxy: true ssIdentifier: ssib044760907 issn: 0387-8023 databaseCode: M~E dateStart: 20200101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBaa7rLLsGEb1q0tcphOhTPbomXx6KQuggHrLhnQm6HINuAMSIouveyw315SchNnG7DHRRAkkSAtWfpIU7QQ7zPbaIeZjVC3GIHLk4iO4TaqGSw7MFnj_ZCfrvX8C3y8yW6ORqNB1NL9djlx3397r-R_ZpXaaF75luw_zOyOKTVQneaXSpphKv9qjj-v3ablwGiPpTlgMKSn_PWq8zVtCRzsGhKU-6t-_S3uxycuS5DTQiLIMpPmkhAmV6aZxPjC1wh05rLU3FTgngq5GRPfU8oC_GCDEqc9R7Pzw867O9txVMfXzZ7eyILo00DmKZnMcAQG81bSlEPPRLr3SQwGUkl8ZrLMSQKWg5iRAIXyYimJWS_MtLjgJqRxma_MPBmpF0tz1cuAsWdElZIrpLDxY4g1at8VNKaWS1loz3omsRhsqpxLmJPehfPPt6UEGSOThkjRx1Ohd4x2Q5dH2OJzNUALafgB0c8HkYIMgE-ib7frCegJVDuyg-Te_DGRQBmhWsSReJKyU4njT3-UA4yWJ7i_HAyQ6xj3NjsBSAToU7ky_FCKbGQT0qb1uoZkpV6mDwcSEexakRHC2SVG664bIKvFc_GsN4nGRVjfL8TRyr4U5wdre0xrezxc26_E4qpczOZR_y-PaGXARK6tU1sjtCqvU3AOYiRTvSH4DXme1JZ_ed-gs5ikNafEcmQY1BgbmyZ1RjaIei2O15t180aMOWMkGSHW1cqC1nbpYmjUEpVu6TlZeyLyoFN1G_K1VP37WbHqFegKuCDtdx18wZH2kxNxRg-hch2XZBmx_cH57PzXYw3m7R_634mn_BoEB92pON7e3TdnBFm3y3M_pQ8jAGr- |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oncofertility+for+neurosurgery&rft.jtitle=Nervous+System+in+Children&rft.au=%E4%BA%94%E5%8D%81%E5%B5%90+%E5%B4%87%E6%B5%A9&rft.au=%E9%87%91%E6%BE%A4+%E5%89%9B%E4%BA%8C&rft.au=Hirai+Maiko&rft.au=%E8%A7%92+%E5%85%89%E4%B8%80%E9%83%8E&rft.date=2021&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%B0%8F%E5%85%90%E7%A5%9E%E7%B5%8C%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0387-8023&rft.eissn=2435-824X&rft.volume=46&rft.issue=4&rft.spage=273&rft.epage=278&rft_id=info:doi/10.34544%2Fjspn.46.4_273&rft.externalDocID=130008132499 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0387-8023&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0387-8023&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0387-8023&client=summon |